Bis(4-methylthiazolyl)isoindoline (4-Mebti) Complexes of Palladium
(400 MHz, CD2Cl2): δ = 8.00 (br.s, 2 H, α-CH), 7.73 (br.s, 10 H, CF3), 123.4 (oCB(ArF)4), 119.0 (CN-CH3), 117.6 (p-CB(ArF)4), 115.4,
β-CH, oCHB(ArF)4), 7.57 (br.s, 4 H, p-CHB(ArF)4), 7.24–7.03 (m, 7 H, 30.8 (CN-CH3), 22.0 (4-MeTh). 19F NMR (282 MHz, C6D6): δ =
CHPh, 5-CHTh), 4.84 (br.s, 2 H, NH2), 2.84 (s, 6 H, 4-MeTh). 13C NMR –62.82. UV/Vis (CH2Cl2): λmax = 243, 281, 295, 368, 390, 421, 447
(100 MHz, CD2Cl2): δ = 167.6, 162.1 (m, BCB(ArF)4), 154.7, 148.8, nm. HRMS (ESI, MeOH): m/z 484.9832; calcd. for [C18H15N6PdS2]+:
136.5, 134.9, 132.9, 130.5, 129.5–128.5 (m, m-CB(ArF)4), 124.7 (q, 484.9829.
1JCF = 272.5 Hz, CF3), 123.2 (oCB(ArF)4), 120.6, 117.6 (p-CB(ArF)4),
116.9, 116.7, 19.5; no signal was detected for the quarternary ipso-
CPh. 19F NMR (188 MHz, CD2Cl2): δ = –65.37. UV/Vis (CH2Cl2):
λmax = 216, 242, 298, 366, 450 nm.
Collection and Reduction of X-ray Data: Intensity data were col-
lected at 130(2) K (5 and 6) or at 193(2) K, using a Stoe IPDS-1 X-ray
diffractometer (Stoe IPDS-2 for 5). Graphite monochromated Mo-Kα
radiation (0.71073 Å) was used. The structures were solved by direct
methods with SIR-92[19] or with SHELXS-97 (6).[20] Refinements were
carried out by full-matrix least-squares techniques against F2 using
SHELXL-97.[20] All non-hydrogen atoms were refined anisotropically.
Hydrogen atoms were assigned to idealized positions if not stated oth-
erwise. Selected crystal data are given in Table 1 and Table 2. Crystal-
lographic data (excluding structure factors) for the structures reported
in this paper have been deposited with the Cambridge Crystallographic
Data Centre as supplementary publication no. CCDC-818999,
-819000, -819001, -819002, -819003, -819004, -819005, -819006.
Copies of the data can be obtained free of charge on application to
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK [Fax: +44-1223-
336-033; E-Mail: deposit@ccdc.cam.ac.uk].
[Pd(4-Mebti)(py)][B(ArF)4] (5): Pyridine (2.5 μL, 32 μmol) and tolu-
ene were used for the preparation. Single crystals of 5 were obtained
after crystallization from dichloromethane/n-pentane at –20 °C. Yield:
23.8 mg (17 μmol, 81 %). calcd. (%) for C53H29N6S2F24BPd: C 45.89,
H 2.11, N 6.06; found: C 45.63, H 2.55, N 5.95. 1H NMR (300 MHz,
CD2Cl2): δ = 8.69–8.67 (m, 2 H, o-CHPy) 8.02 (t, J = 6.8 Hz, 1 H,
p-CHPy), 7.93–7.89 (m, 2 H, α-CH), 7.72 (br.s, 10 H, β-CH,
o-CHB(ArF)4), 7.65–7.63 (m, 2 H, m-CHPy), 7.52 (s, 4 H, p-CHB(ArF)4),
6.82 (s, 2 H, 5-CHTh), 1.02 (s, 6 H, 4-MeTh). 13C NMR (100 MHz,
CD2Cl2): δ = 170.1, 162.2 (m, BCB(ArF)4), 153.6, 149.0, 141.6, 136.4,
1
134.9, 132.7, 129.7–128.4 (m, m-CB(ArF)4), 128.1, 124.9 (q, JCF
=
273.1 Hz, CF3), 123.5 (oCB(ArF)4), 122.9, 117.6 (p-CB(ArF)4), 116.1,
17.5. 19F NMR (282 MHz, CD2Cl2): δ = –62.83. UV/Vis (CH2Cl2):
λmax = 229, 301, 387, 487 nm.
Acknowledgement
[Pd(4-Mebti)(2,6-Me2py)] [B(ArF)4] (6): 2,6-Lutidine (14.8 mg, 139
μmol) and toluene were used for the preparation. Single crystals of
6 grew upon crystallization from toluene/n-pentane at –20 °C. Yield:
12.1 mg (9 μmol, 41 %). calcd. (%) for C55H33N6S2F24BPd: C 46.68,
Support for this research by the Deutsche Forschungsgemeinschaft is
gratefully acknowledged. The authors thank Anne Scheja and Nicola
Biermann for their help, and Dr. Thomas Linder for a sample of 1-n-
butyl-3-methylimidazolin-2-ylidene.
1
H 2.35, N 5.94; found: C 46.26, H 2.57, N 5.81. H NMR (400 MHz,
CD2Cl2): δ = 8.00–7.99 (m, 2 H, α-CHTh), 7.85 (t, J = 8.0 Hz, 1 H,
p-CHPy), 7.72 (br.s, 10 H, β-CH, o-CHB(ArF)4), 7.55 (s, 4 H,
p-CHB(ArF)4), 7.37 (d, J = 8.0 Hz, 2 H, m-CHPy), 6.83 (s, 2 H, 5-CHTh),
3.04 (s, 6 H, o-MePy), 1.08 (s, 6 H, 4-MeTh). 13C NMR (100 MHz,
CD2Cl2): δ = 170.2, 162.1 (m, BCB(ArF)4), 161.8, 153.9, 149.1, 141.8,
136.3, 134.9, 132.8, 129.6–128.5 (m, m-CB(ArF)4), 125.7, 124.7 (q,
1JCF = 273.2 Hz, CF3), 123.5 (oCB(ArF)4), 117.5 (p-CB(ArF)4), 116.3,
26.6, 16.9. 19F NMR (188 MHz, CD2Cl2): δ = –62.84. UV/Vis
(CH2Cl2): λmax = 230, 241, 299, 393, 501 nm.
References
[1] a) F. Blank, C. Janiak, Coord. Chem. Rev. 2009, 253, 827–861;
b) P.-G. Lassahn, V. Lozan, C. Janiak, Dalton Trans. 2003, 4437–
4450; c) D. J. Tempel, L. K. Johnson, R. L. Huff, P. S. White, M.
Brookhart, J. Am. Chem. Soc. 2000, 122, 6686–6700; d) L. K.
Johnson, C. M. Killian, M. Brookhart, J. Am. Chem. Soc. 1995,
117, 6414–6415; e) S. Mecking, L. K. Johnson, L. Wang, M.
Brookhart, J. Am. Chem. Soc. 1998, 120, 888–899; f) G. J. P.
Britovsek, V. C. Gibson, B. S. Kimberly, P. J. Maddox, S. J.
McTravish, G. A. Solan, A. J. P. White, D. J. Williams, Chem.
Commun. 1998, 849–850; g) R. J. Piccolini, ChemTech 1999, 29,
39–40; h) D. T. Thompson, Plat. Met. Rev. 1996, 40, 78–79.
[2] a) A. F. Bella, A. Ruiz, C. Claver, F. Sepúlveda, F. A. Jalón, B. R.
Manzano, J. Organomet. Chem. 2008, 693, 1269–1275; b) Z. Ji-
ang, S. E. Adams, A. Sen, Macromolecules 1994, 27, 2694–2700;
c) M. Barsacchi, A. Batistini, G. Consiglio, U. W. Suter, Macro-
molecules 1992, 25, 3604–3606; d) B. Milani, A. Alessio, G.
Mestroni, E. Zangrando, L. Randaccio, G. Consiglio, J. Chem.
Soc., Dalton Trans. 1996, 1021–1029; e) M. Brookhart, M. I.
Wagner, J. Am. Chem. Soc. 1996, 118, 7219–7220; f) S. Bartolini,
C. Carfagna, A. Musco, Macromol. Rapid Commun. 1995, 16, 9–
14; g) A. Bastero, A. Ruiz, C. Claver, A. Bella, B. Milani, B.
Moreno-Lara, F. A. Jalón, B. R. Manzano, Adv. Synth. Catal.
2005, 347, 839–846; h) J. M. Benito, E. de Jesús, F. J.
de la Mata, J. C. Flores, R. Gómez, Organometallics 2006, 25,
3045–3055; i) G. P. Belov, Russ. Chem. Bull. 2002, 51, 1605–
1615; j) C. Bianchini, A. Meli, Coord. Chem. Rev. 2002, 225, 35–
66.
[Pd(4-Mebti)(MeCN)][B(ArF)4] (7): A toluene/acetonitrile mixture
(2:1) was used for the preparation. Single crystals of 7 were obtained
after crystallization from toluene/n-pentane (7), or from dichlorometh-
ane/acetonitrile/n-pentane (7'), at –20 °C. Yield: 19.1 mg (13 μmol,
1
64 %). H NMR (400 MHz, C6D6): δ = 8.34 (br.s, 8 H, o-CHB(ArF)4),
7.81–7.78 (m, 2 H, α-CH), 7.66 (br.s, 4 H, p-CHB(ArF)4), 7.03–7.00 (m,
2 H, β-CH), 5.94 (s, 2 H, 5-CHTh), 1.90 (s, 6 H, 4-MeTh), 0.62 (s, 3
H, MeCN). 13C NMR (100 MHz, C6D6): δ = 166.7, 162.7 (m,
BCB(ArF)4), 153.3, 148.2, 136.2, 135.4, 133.0, 130.5–129.5 (m,
1
m-CB(ArF)4), 124.7 (q, JCF = 270.9 Hz, CF3), 123.3 (oCB(ArF)4), 118.1
(p-CB(ArF)4), 117.0 (Me-CN), 115.4, 19.9, –0.12 (H3C-CN). 19F NMR
(282 MHz, C6D6): δ = –62.02. UV/Vis (CH2Cl2): λmax = 231, 271, 299,
368, 390, 448 nm. HRMS (APCI, MeCN): m/z 484.9828; calcd. for
[C18H15N6PdS2]+: 484.9829.
[Pd(4-Mebti)(MeNC)][B(ArF)4] (8): Methylisocyanide (1.5 μL, 37
μmol) and dichloromethane were used for the preparation. Single crys-
tals of 8 were obtained after crystallization from dichloromethane/
n-pentane at –20 °C. Yield: 20.1 mg (15 μmol, 71 %). 1H NMR
(300 MHz, C6D6): δ = 8.08–8.03 (m, 2 H, α-CH), 7.76–7.72 (m, 10
H, β-CH, o-CHB(ArF)4), 7.57 (s, 4 H, p-CHB(ArF)4), 7.11 (s, 2 H,
5-CHTh), 3.58 (s, 3 H, CN-Me), 2.68 (s, 6 H, 4-MeTh). 13C NMR
(75 MHz, C6D6): δ = 168.0, 161.9 (m, BCB(ArF)4), 154.2, 149.1, 136.6,
[3] a) M. Bröring, S. Prikhodovski, S. Köhler, Acta Crystallogr., Sect.
C 2007, 63, m68–m70; b) M. Bröring, S. Prikhodovski, C. D.
Brandt, E. Cónsul Tejero, Z. Anorg. Allg. Chem. 2007, 633, 458–
464; c) M. Bröring, C. D. Brandt, S. Link, Inorg. Chim. Acta
2005, 358, 3122–3134; d) M. Bröring, C. D. Brandt, S. Stellwag,
Chem. Commun. 2003, 2344–2345; e) M. Bröring, C. D. Brandt,
1
134.9, 133.1, 129.6–128.4 (m, m-CB(ArF)4), 124.7 (q, JCF = 271.5 Hz,
Z. Anorg. Allg. Chem. 2011, 1769–1776
© 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
1775